Alterations in striatal oxidative stress level produced by pharmacological manipulation of dopamine as shown by a novel synthetic marker molecule.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neuropharmacology

• Publication date

  2011-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuropharm.2011.03.006PMID 21414328
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule

  2010cited by this paper
• Amphetamine toxicities

  2010cited by this paper
• Respiration-dependent H2O2 Removal in Brain Mitochondria via the Thioredoxin/Peroxiredoxin System*

  2010cited by this paper
• Characterization of Monoamine Oxidases in Mesenchymal Stem Cells: Role in Hydrogen Peroxide Generation and Serotonin-Dependent Apoptosis

  2010cited by this paper
• A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease

  2010cited by this paper
• Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease

  2009cited by this paper
• A double-blind, delayed-start trial of rasagiline in Parkinson's disease.

  2009cited by this paper
• Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects.

  2009cited by this paper
• Oxidative Stress in Parkinson's Disease

  2008cited by this paper
• Characterization of oxidative stress in blood from diabetic vs. hypercholesterolaemic patients, using a novel synthesized marker

  2008cited by this paper
• Influence of chronic exercise on reserpine-induced oxidative stress in rats: behavioral and antioxidant evaluations.

  2008cited by this paper
• An exogenous marker: a novel approach for the characterization of oxidative stress.

  2007cited by this paper
• Neurotoxicity of substituted amphetamines: Molecular and cellular mechanisms

  2007cited by this paper
• Neurotoxicity and Metabolism of the Catecholamine-Derived 3,4-Dihydroxyphenylacetaldehyde and 3,4-Dihydroxyphenylglycolaldehyde: The Role of Aldehyde Dehydrogenase

  2007influential reference
• The pathogenesis of cell death in Parkinson's disease

  2006cited by this paper
• Effect of ketanserin and amphetamine on nigrostriatal neurotransmission and reactive oxygen species in Parkinsonian rats. In vivo microdialysis study.

  2006cited by this paper
• Exogenous N-linoleoyl tyrosine marker as a tool for the characterization of cellular oxidative stress in macrophages

  2006cited by this paper
• Detection and quantitation of a ring-hydroxylated metabolite of the antidepressant drug tranylcypromine

  2005cited by this paper
• The biogenic trace amine tyramine induces a pronounced hydroxyl radical production via a monoamine oxidase dependent mechanism: an in vivo microdialysis study in mouse striatum.

  2004influential reference
• Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione/reduced glutathione ratio (GSSG/GSH) enhancement in rats.

  2003influential reference
• Oxidative stress in Parkinson's disease

  2003cited by this paper
• Cholesterol, Linoleic Acid or/and Tyrosine Yield Different Spectra of Products when Oxidized Alone or in a Mixture: Studies in Various Oxidative Systems

  2003cited by this paper
• Hydrogen peroxide production by monoamine oxidase during ischemia/reperfusion.

  2002cited by this paper
• Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO)

  2002influential reference
• Effects of amphetamine and sydnocarb on dopamine release and free radical generation in rat striatum.

  2001cited by this paper
• Dopamine‐Induced Apoptosis Is Mediated by Oxidative Stress and Is Enhanced by Cyanide in Differentiated PC12 Cells

  2000cited by this paper
• Methamphetamine‐induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice

  2000cited by this paper
• Reactive oxygen species production by monoamine oxidases in intact cells

  1999cited by this paper
• Amphetamine induces hydroxyl radical formation in the striatum of rats.

  1997cited by this paper
• Effect of Long‐Term Treatment with Selective Monoamine Oxidase A and B Inhibitors on Dopamine Release from Rat Striatum In Vivo

  1996cited by this paper
• Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease.

  1996cited by this paper
• Amphetamine: effects on catecholamine systems and behavior.

  1993cited by this paper
• Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism.

  1993cited by this paper
• The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it

  1992cited by this paper
• New directions in monoamine oxidase A and B selective inhibitors and substrates.

  1991cited by this paper
• Toxicity of 6‐hydroxydopamine and dopamine for dopaminergic neurons in culture

  1990cited by this paper
• Oxidative stress: a role in the pathogenesis of Parkinson's disease.

  1990cited by this paper
• Partial damage to nigrostriatal bundle: compensatory changes and the action of L-dopa.

  1990cited by this paper
• Dopamine turnover and glutathione oxidation: implications for Parkinson disease.

  1989influential reference

• Design, synthesis, and evaluation of N-methyl-propargylamine derivates as isoform-selective monoamine oxidases inhibitors for the treatment of nervous system diseases.

  2023cites this paper
• Smelling the Disease: Diagnostic Potential of Breath Analysis

  2023cites this paper
• Lead (Pb) exposure induces dopaminergic neurotoxicity in Caenorhabditis elegans: Involvement of the dopamine transporter

  2019cites this paper
• An investigation of indanone derivatives as inhibitors of monoamine oxidase

  2018cites this paper
• Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson’s disease

  2018cites this paper
• Altered Volatile Organic Compound Profile in Transgenic Rats Bearing A53T Mutation of Human α-Synuclein: Comparison with Dopaminergic and Serotonergic Denervation.

  2017cites this paper
• Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology

  2016cites this paper
• Extracellular dopamine and alterations on dopamine transporter are related to reserpine toxicity in Caenorhabditis elegans

  2016cites this paper
• The Impact of Oxidative Stress on Dopaminergic Neurotransmission

  2015cites this paper
• Therapeutic Effects of Fucoidan in 6‐Hydroxydopamine‐Lesioned Rat Model of Parkinson's disease: Role of NADPH oxidase‐1

  2014cites this paper
• Detection of Alzheimer's and Parkinson's disease from exhaled breath using nanomaterial-based sensors.

  2013cites this paper
• Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.

  2013cites this paper
• Exogenous markers for the characterization of human diseases associated with oxidative stress.

  2013cites this paper
• Detection of asymptomatic nigrostriatal dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensors.

  2012cites this paper